Live attenuated human parainfluenza virus type 2 vaccine (NIAID)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLive attenuated human parainfluenza virus type 2 vaccine (NIAID)

Drug Alias NamerHPIV-2rV94(15C )/948L/delta-1724

ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsParamyxoviridae Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)

Active IndicationsN/A

Inactive IndicationsParamyxoviridae Infections

Other Information

ATC CodeN/A